Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4
Akio Takehara(The University of Tokyo), Hidewaki Nakagawa(RIKEN Center for Integrative Medical Sciences), Hiroaki Ohigashi(Teine Keijinkai Hospital), Hidetoshi Eguchi(Osaka Gakuin University), Toyomasa Katagiri(National Institute of Biomedical Innovation, Health and Nutrition), Yusuke Nakamura(Rissho University), Tsutomu Kasugai(Osaka Medical Center for Cancer and Cardiovascular Diseases), Masayo Hosokawa(The University of Tokyo), Osamu Ishikawa(Gunma University)
Cited by 83
Related Papers
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy
|Nature|1998|804
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
|Nature Genetics|2008|728